PLEASANTON, Calif., Feb. 14, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Swann 2012 Global Healthcare Conference on Thursday, February 16.
Taylor C. Harris, Senior Director of Investor Relations and Business Development, will provide an update on the company, beginning at 4:00 p.m., Eastern Standard Time ( 1:00 p.m., Pacific Standard Time).
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts